- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Debra Patt Acknowledges Progress Made Against Cancer
One of the important findings from the American Society of Clinical Oncology’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
One of the important findings from the American Society of Clinical Oncology (ASCO)’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
Transcript (slightly modified)
What were some of the key findings from ASCO’s annual report on the state of cancer care in the United States?
Well, I think one of the most important things that we recognize today is that while we’re seeing more cancer, cancer mortality continues to go down. So one of the findings in the report was that cancer mortality, in fact, has gone down by 1.5% per year for the last decade. I think that’s representative of progress: progress in screening and early detection, progress in more effective immediate therapies, progress in long-term therapies, and even in patients with incurable illness that they live longer. Those are great successes.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
